Indraprastha Medical (NSE:INDRAMEDCO) Accounts Payable & Accrued Expense: ₹1,282 Mil (As of Mar. 2026)


NSE:INDRAMEDCO Indraprastha Medical Corp Ltd NSE:INDRAMEDCO
84 GF Score
Price ₹395.15
GF Value ₹417.38
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Indraprastha Medical Accounts Payable & Accrued Expense?

Indraprastha Medical NSE:INDRAMEDCO +0.15% 84 Accounts Payable & Accrued Expense is ₹1,282 Mil as of Mar. 2026. GuruFocus rates NSE:INDRAMEDCO with a GF Score™ of 84/100 and a GF Value™ of ₹417.38 (Fairly Valued). The stock has 2 warning signs investors should review.

Indraprastha Medical's quarterly accounts payable & accrued expense declined from Sep. 2025 (₹1,173 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,282 Mil).

Indraprastha Medical's annual accounts payable & accrued expense increased from Mar. 2024 (₹1,402 Mil) to Mar. 2025 (₹1,486 Mil) but then declined from Mar. 2025 (₹1,486 Mil) to Mar. 2026 (₹1,282 Mil).

Indraprastha Medical Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Indraprastha Medical's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indraprastha Medical Accounts Payable & Accrued Expense Chart

Indraprastha Medical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 788.00 1,047.60 1,401.80 1,486.00 1,281.50

Indraprastha Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,486.00 0.00 1,172.90 0.00 1,281.50
NSE:INDRAMEDCO
84GF Score
Indraprastha Medical Corp Ltd NSE:INDRAMEDCO
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indraprastha Medical Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of ₹1,282 Mil mean?
Indraprastha Medical (NSE:INDRAMEDCO) has a Accounts Payable & Accrued Expense of ₹1,282 Mil as of Mar. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Indraprastha Medical and its competitors.
Is Indraprastha Medical's Accounts Payable & Accrued Expense too high?
Indraprastha Medical's current Accounts Payable & Accrued Expense is ₹1,282 Mil. Overall, Indraprastha Medical has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's Accounts Payable & Accrued Expense compare to HCA and THC?
Indraprastha Medical's Accounts Payable & Accrued Expense of ₹1,282 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Healthcare Providers & Services company?
A good Accounts Payable & Accrued Expense depends on the Healthcare Providers & Services industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Indraprastha Medical and its competitors. Indraprastha Medical's current Accounts Payable & Accrued Expense is ₹1,282 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (NSE:INDRAMEDCO) is currently considered Fairly Valued. The stock's GF Value™ is ₹417.38, compared to a current price of ₹395.15 — trading 5.3% below its estimated fair value. The current Accounts Payable & Accrued Expense is ₹1,282 Mil. Indraprastha Medical's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Indraprastha Medical (NSE:INDRAMEDCO), the current Accounts Payable & Accrued Expense is ₹1,282 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indraprastha Medical (NSE:INDRAMEDCO) Overvalued in 2026?

Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued. The current stock price of ₹395.15 is trading 5.3% below its estimated GF Value™ of ₹417.38. GuruFocus considers Indraprastha Medical to be Fairly Valued.

Key valuation signals for NSE:INDRAMEDCO:

  • Accounts Payable & Accrued Expense: ₹1,282 Mil
  • GF Value™: ₹417.38 vs. price of ₹395.15 (5.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the NSE:INDRAMEDCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indraprastha Medical Business Description

Other Exchanges 532150:India
Address Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
84GF Score

Get the complete analysis for NSE:INDRAMEDCO

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹395.15
Price
₹417.38
GF Value